Although Zofran is widely prescribed during pregnancy for morning sickness or hyperemesis gravidarum (HG), there is growing evidence that the medication may increase the risk of birth defects and congenital malformations for children. While further studies on the safety of Zofran in pregnancy are needed, there… Read More
By Austin Kirk
March 13, 2015 | 6 Comments
Homeowners throughout the United States have been reporting problems with Lumber Liquidators laminate flooring, indicating that it may fail within a short amount of time. In addition, recent testing revealed that some Chinese flooring sold by the company may release high levels of toxic formaldehyde. (more…) Read More
By Austin Kirk
March 5, 2015 | 3 Comments
Following a continuing stream of evidence establishing a link between side effects of testosterone drugs and cardiovascular problems, the FDA announced this week that new label warnings will be required for popular drugs like Androgel, Axiron, Testim and other "low T" treatments. The lawyers at Saiontz… Read More
By Austin Kirk
March 3, 2015 | No Comments
The product liability lawyers at Saiontz & Kirk, P.A. are reviewing potential Zofran lawsuits for children born with birth defects or malformations that may have been caused by exposure to the morning sickness drug during the first trimester of pregnancy. Although Zofran has been widely prescribed… Read More
By Austin Kirk
February 13, 2015 | 3 Comments
The product liability lawyers at Saiontz & Kirk, P.A. are continuing to review peripheral neuropathy lawsuits for users of Levaquin and other fluoroquinolone antibiotics, such as Avelox, Cipro and others. (more…) Read More
By Austin Kirk
February 2, 2015 | 2 Comments
The need for more testing of testosterone drugs is becoming increasingly clear, in the face of a growing industry and a mounting number of men who are allegedly suffering heart attacks, strokes, blood clots and sudden death while using widely advertised "Low T" drugs. (more…) Read More
By Austin Kirk
December 29, 2014 | No Comments
UPDATE: On August 1, 2017, a $300 million Benicar settlement was reached with the drug makers to resolve certain claims for injuries stemming from use of Benicar, Benicar HCT, Azor or Tribenzor prior to May 2015. Saiontz & Kirk, P.A. is longer reviewing new cases. The… Read More
By Austin Kirk
December 22, 2014 | 2 Comments
[box_headline]UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.[/box_headline] With a growing number of Xarelto injury lawsuits continuing to be filed in U.S. District Courts… Read More
By Austin Kirk
December 15, 2014 | 1 Comment
[box_headline]UPDATE: Following a $775 million global settlement announced in March 2019, Saiontz & Kirk, P.A. is no longer reviewing new Xarelto cases. This page is provided for informational purposes only.[/box_headline] While Xarelto has been promoted as a superior alternative to warfarin, with the drug makers claiming… Read More
By Austin Kirk
November 24, 2014 | No Comments
Over the past decade, millions of people have used the hypertension drugs Benicar, Azor and Tribenzor, which all contain the active ingredient olmesartan. Last year, the FDA required the Daiichi Sankyo and Forest Laboratories to add new warnings about the risk of serious and potentially life-threatening… Read More
By Austin Kirk
November 19, 2014 | No Comments